Literature DB >> 5116139

Interpretation of the methylene blue reduction test of human plasma and the possible cancer protecting effect of selenium.

G N Schrauzer, W J Rhead.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5116139     DOI: 10.1007/bf02138885

Source DB:  PubMed          Journal:  Experientia        ISSN: 0014-4754


× No keyword cloud information.
  5 in total

1.  The binding of phenolsulfonphthalein by serum and by albumin isolated from serum in cancer.

Authors:  C HUGGINS; E V JENSEN
Journal:  Cancer Res       Date:  1949-12       Impact factor: 12.701

2.  Chemical tests for malignancy.

Authors:  M M BLACK; F D SPEER
Journal:  Am J Clin Pathol       Date:  1950-05       Impact factor: 2.493

3.  Sodium selenite Se 75. A more specific agent for scanning tumors.

Authors:  R R Cavalieri; K G Scott
Journal:  JAMA       Date:  1968-10-14       Impact factor: 56.272

4.  Possible protective effect of selenium against human cancer.

Authors:  R J Shamberger; D V Frost
Journal:  Can Med Assoc J       Date:  1969-04-12       Impact factor: 8.262

5.  Electron transfer reactions catalyzed by vitamin B 12 and related compounds: the reduction of dyes and of riboflavin by thiols.

Authors:  G N Schrauzer; J W Sibert
Journal:  Arch Biochem Biophys       Date:  1969-03       Impact factor: 4.013

  5 in total
  3 in total

1.  The distribution of selenium and cancer mortality in the continental United States.

Authors:  U M Cowgill
Journal:  Biol Trace Elem Res       Date:  1983-08       Impact factor: 3.738

2.  Magnesium (and trace substance) deficiencies in the pathogenesis of cancer.

Authors:  M S Seelig
Journal:  Biol Trace Elem Res       Date:  1979-12       Impact factor: 3.738

Review 3.  Selenium as an essential micronutrient: roles in cell cycle and apoptosis.

Authors:  Huawei Zeng
Journal:  Molecules       Date:  2009-03-23       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.